{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:19:51Z","timestamp":1773717591555,"version":"3.50.1"},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["surgpath.theclinics.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.path.2024.04.008","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T04:13:29Z","timestamp":1720930409000},"page":"453-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Minimally Invasive, Maximally Effective"],"prefix":"10.1016","volume":"17","author":[{"given":"Ricella","family":"Souza da Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib1","doi-asserted-by":"crossref","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.path.2024.04.008_bib2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/dc.24663","article-title":"Serous fluid cytopathology: Past, present, and future","volume":"49","author":"Michael","year":"2021","journal-title":"Diagn Cytopathol"},{"issue":"5","key":"10.1016\/j.path.2024.04.008_bib3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/dc.24392","article-title":"Molecular testing on serous effusions","volume":"49","author":"Davidson","year":"2021","journal-title":"Diagn Cytopathol"},{"issue":"2","key":"10.1016\/j.path.2024.04.008_bib4","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jmoldx.2017.10.007","article-title":"Comprehensive genomic profiling of malignant effusions in patients with metastatic lung adenocarcinoma","volume":"20","author":"Yang","year":"2018","journal-title":"J\u00a0Mol Diagn"},{"issue":"4","key":"10.1016\/j.path.2024.04.008_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.21037\/tlcr.2019.07.05","article-title":"Sensitive molecular testing methods can demonstrate NSCLC driver mutations in malignant pleural effusion despite non-malignant cytology","volume":"8","author":"Steinfort","year":"2019","journal-title":"Transl Lung Cancer Res"},{"issue":"9","key":"10.1016\/j.path.2024.04.008_bib6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/dc.24410","article-title":"Current applications of molecular testing on body cavity fluids","volume":"48","author":"Pinto","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.path.2024.04.008_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.25259\/Cytojournal_55_2020","article-title":"Molecular testing on serous effusion: An update","volume":"18","author":"Sahu","year":"2021","journal-title":"CytoJournal"},{"key":"10.1016\/j.path.2024.04.008_bib8","series-title":"Lung cancer - strategies for diagnosis and treatment","article-title":"Pleural effusions in lung cancer: detection and treatment","author":"Medenica","year":"2018"},{"issue":"9","key":"10.1016\/j.path.2024.04.008_bib9","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.5858\/arpa.2019-0429-OA","article-title":"Malignancies in pleural, peritoneal, and pericardial effusions","volume":"144","author":"Dermawan","year":"2020","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.path.2024.04.008_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-023-02424-6","article-title":"The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review","author":"Allan","year":"2023","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/dc.25067","article-title":"The basics of commonly used molecular techniques for\u00a0diagnosis, and application of molecular testing in cytology","volume":"51","author":"Turner","year":"2023","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/cyt.12654","article-title":"Management of cytological material, pre-analytical procedures and bio-banking in effusion cytopathology","volume":"30","author":"Engels","year":"2019","journal-title":"Cytopathology"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/pp-2016-0001","article-title":"Pre-analytical issues in effusion cytology","volume":"1","author":"Michael","year":"2016","journal-title":"Pleura Peritoneum"},{"issue":"3","key":"10.1016\/j.path.2024.04.008_bib14","first-page":"203","article-title":"Effect of storage time of pleural effusions on immunocytochemical cell surface analysis of tumor cells","volume":"14","author":"Guzman","year":"1992","journal-title":"Anal Quant Cytol Histol"},{"issue":"3","key":"10.1016\/j.path.2024.04.008_bib15","first-page":"267","article-title":"Effect of storage time on the analysis of lymphocyte subpopulations in pleural effusions","volume":"37","author":"Guzman","year":"1993","journal-title":"Acta Cytol"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/dc.20587","article-title":"Diagnostic effects of prolonged storage on fresh effusion samples","volume":"35","author":"Manosca","year":"2007","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.path.2024.04.008_bib17","series-title":"The international system for serous fluid cytopathology","year":"2020"},{"issue":"7","key":"10.1016\/j.path.2024.04.008_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/cncy.22577","article-title":"Reassessing the optimal volume for malignancy detection in serous fluid cytology","volume":"130","author":"Coconubo","year":"2022","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"10.1016\/j.path.2024.04.008_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jasc.2016.04.004","article-title":"A\u00a0specimen volume of \u226580 mL improves cytologic sensitivity for malignant ascites: a retrospective analysis of 2665 cases","volume":"5","author":"Rooper","year":"2016","journal-title":"J\u00a0Am Soc Cytopathol"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/ajcp\/aqv021","article-title":"A\u00a0minimum volume of more than 60 mL is necessary for adequate cytologic diagnosis of malignant pericardial effusions","volume":"145","author":"Rooper","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2024.04.008_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.25259\/CMAS_02_03_2021","article-title":"Approach to diagnostic cytopathology of serous effusions","volume":"18","author":"Shidham","year":"2021","journal-title":"CytoJournal"},{"issue":"6","key":"10.1016\/j.path.2024.04.008_bib22","first-page":"665","article-title":"The value of multiple fluid specimens in the cytological diagnosis of malignancy","volume":"7","author":"Garcia","year":"1994","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.path.2024.04.008_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/cyt.13218","article-title":"The International system for reporting serous fluid cytopathology: The initial project survey","volume":"34","author":"VandenBussche","year":"2023","journal-title":"Cytopathology"},{"key":"10.1016\/j.path.2024.04.008_bib24","article-title":"Review of the impact of the International System for Serous Fluid Cytopathology","author":"Mikou","year":"2023","journal-title":"Cytopathology"},{"issue":"6","key":"10.1016\/j.path.2024.04.008_bib25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.3390\/diagnostics11061126","article-title":"Cytohistological Correlation in Pleural Effusions Based on the International System for Reporting Serous Fluid Cytopathology","volume":"11","author":"Pinto","year":"2021","journal-title":"Diagnostics"},{"issue":"5","key":"10.1016\/j.path.2024.04.008_bib26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/dc.24440","article-title":"Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center","volume":"49","author":"Lobo","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.path.2024.04.008_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.25259\/CMAS_02_07_2021","article-title":"Diagnostic cytopathology of peritoneal washings","volume":"19","author":"Zuna","year":"2022","journal-title":"CytoJournal"},{"issue":"5","key":"10.1016\/j.path.2024.04.008_bib28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/dc.24653","article-title":"Root cause analysis of indeterminate diagnoses in serous fluids cytopathology","volume":"49","author":"Gokozan","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.path.2024.04.008_bib29","series-title":"The international system for serous fluid cytopathology","first-page":"239","article-title":"Cytopreparatory techniques","author":"Russell","year":"2020"},{"issue":"3","key":"10.1016\/j.path.2024.04.008_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.path.2018.05.003","article-title":"Updates in effusion cytology","volume":"11","author":"Lepus","year":"2018","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.path.2024.04.008_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.25259\/CMAS_02_10_2021","article-title":"Serous fluid: Metastatic sarcomas, melanoma, and other non-epithelial neoplasms","volume":"19","author":"Pantanowitz","year":"2022","journal-title":"CytoJournal"},{"issue":"3","key":"10.1016\/j.path.2024.04.008_bib32","first-page":"e13762","article-title":"Lung Adenocarcinoma Presenting as Malignant Pericardial Effusion\/Tamponade","volume":"13","author":"Vemireddy","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.path.2024.04.008_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.25259\/CMAS_02_11_2021","article-title":"Serous cavity metastasis: Evaluation of unknown primary","volume":"19","author":"Jhala","year":"2022","journal-title":"CytoJournal"},{"key":"10.1016\/j.path.2024.04.008_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.25259\/CMAS_02_12_2021","article-title":"Serous fluids and hematolymphoid disorders","volume":"19","author":"Gabali","year":"2022","journal-title":"CytoJournal"},{"key":"10.1016\/j.path.2024.04.008_bib35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.25259\/CMAS_02_13_2021","article-title":"Flow cytometry, molecular analysis, and other special techniques (in Serous Fluid Cytopathology)","volume":"19","author":"Gabali","year":"2022","journal-title":"CytoJournal"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cncy.22342","article-title":"Cytomorphology of primary pulmonary NUT carcinoma in different cytology preparations","volume":"129","author":"Dutta","year":"2021","journal-title":"Cancer Cytopathology"},{"issue":"Suppl 8","key":"10.1016\/j.path.2024.04.008_bib37","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/cncy.22021","article-title":"Ancillary studies in pleural, pericardial, and peritoneal effusion cytology","volume":"126","author":"Sundling","year":"2018","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.path.2024.04.008_bib38","doi-asserted-by":"crossref","first-page":"19785","DOI":"10.1038\/srep19785","article-title":"Diagnostic value of thyroid transcription factor-1 for pleural or other serous metastases of pulmonary adenocarcinoma: a meta-analysis","volume":"6","author":"Shen","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.path.2024.04.008_bib39","first-page":"293","article-title":"Comprehensive review of metastatic breast carcinoma in cytology specimens","volume":"3","author":"Baskota","year":"2022","journal-title":"J\u00a0Mol Pathol"},{"issue":"11","key":"10.1016\/j.path.2024.04.008_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/dc.25195","article-title":"Comparative expression of TRPS1, GATA3, SOX10, mammaglobin, and GCDFP-15 in effusion specimens with breast carcinoma","volume":"51","author":"Bradt","year":"2023","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.path.2024.04.008_bib41","doi-asserted-by":"crossref","first-page":"9507","DOI":"10.1038\/srep09507","article-title":"Diagnostic accuracy of calretinin for malignant mesothelioma in serous effusions: a meta-analysis","volume":"5","author":"Li","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib42","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.5301\/jbm.5000181","article-title":"Diagnostic accuracy of epithelial membrane antigen for malignant effusions: a meta-analysis","volume":"31","author":"Lin","year":"2016","journal-title":"Int J Biol Markers"},{"issue":"5","key":"10.1016\/j.path.2024.04.008_bib43","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/cyt.12993","article-title":"Immunocytochemistry for diagnostic cytopathology-A practical guide","volume":"32","author":"Kanber","year":"2021","journal-title":"Cytopathology"},{"issue":"0","key":"10.1016\/j.path.2024.04.008_bib44","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group","volume":"0","author":"Mosele","year":"2024","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.path.2024.04.008_bib45","doi-asserted-by":"crossref","first-page":"102223","DOI":"10.1016\/j.ctrv.2021.102223","article-title":"Precision medicine in breast cancer: From clinical trials to clinical practice","volume":"98","author":"Crimini","year":"2021","journal-title":"Cancer Treat Rev"},{"issue":"7","key":"10.1016\/j.path.2024.04.008_bib46","doi-asserted-by":"crossref","first-page":"e002459","DOI":"10.1136\/jitc-2021-002459","article-title":"Systematic review of combinations of targeted or immunotherapy in advanced solid tumors","volume":"9","author":"Tan","year":"2021","journal-title":"J\u00a0Immunother Cancer"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/dc.25043","article-title":"PD-L1 immunohistochemical testing: A review with reference to cytology specimens","volume":"51","author":"Layfield","year":"2023","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"10.1016\/j.path.2024.04.008_bib48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/dc.24955","article-title":"Program death ligand-1 immunocytochemistry in lung cancer cytological samples: A systematic review","volume":"50","author":"Satturwar","year":"2022","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"10.1016\/j.path.2024.04.008_bib49","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.21037\/jtd.2020.02.06","article-title":"PD-L1 expression in malignant pleural effusion samples and its correlation with oncogene mutations in non-small cell lung cancer","volume":"12","author":"Song","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib50","doi-asserted-by":"crossref","first-page":"00787","DOI":"10.1183\/23120541.00787-2020","article-title":"High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer","volume":"7","author":"Hagmeyer","year":"2021","journal-title":"ERJ Open Res"},{"issue":"6","key":"10.1016\/j.path.2024.04.008_bib51","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cncy.22401","article-title":"Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma","volume":"129","author":"Mansour","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.path.2024.04.008_bib52","doi-asserted-by":"crossref","DOI":"10.1111\/cyt.13265","article-title":"Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma","author":"Mansour","year":"2023","journal-title":"Cytopathology"},{"issue":"3","key":"10.1016\/j.path.2024.04.008_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jtho.2017.12.001","volume":"13","author":"Lindeman","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.path.2024.04.008_bib54","author":"Roy-Chowdhuri","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"1\u20132","key":"10.1016\/j.path.2024.04.008_bib55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000497187","article-title":"Overview of molecular testing of cytology specimens","volume":"64","author":"Huang","year":"2020","journal-title":"Acta Cytol"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib56","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jasc.2016.08.005","article-title":"Rapid removal of cytology slide coverslips for DNA and RNA isolation","volume":"6","author":"Zhou","year":"2017","journal-title":"J\u00a0Am Soc Cytopathol"},{"issue":"5","key":"10.1016\/j.path.2024.04.008_bib57","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/cyt.12974","article-title":"Next generation sequencing in cytology","volume":"32","author":"Pisapia","year":"2021","journal-title":"Cytopathology"},{"key":"10.1016\/j.path.2024.04.008_bib58","article-title":"Expert opinion on NSCLC small specimen biomarker testing \u2014 Part 1: Tissue collection and management","author":"Penault-Llorca","year":"2022","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.path.2024.04.008_bib59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3390\/jmp3040028","article-title":"Optimal assessment of metastatic breast carcinoma: the value of cytopathology combined with molecular analysis","volume":"3","author":"Souza Da Silva","year":"2022","journal-title":"JMP"},{"issue":"16","key":"10.1016\/j.path.2024.04.008_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164194","article-title":"Epidemiology and clinical aspects of malignant pleural mesothelioma","volume":"13","author":"Brims","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.path.2024.04.008_bib61","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2018.07.041","article-title":"Highlights of the 14th international mesothelioma interest group meeting: Pathologic separation of benign from malignant mesothelial proliferations and histologic\/molecular analysis of malignant mesothelioma subtypes","volume":"124","author":"Churg","year":"2018","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.path.2024.04.008_bib62","article-title":"The cytologic diagnosis of mesothelioma: are we there yet?","volume":"12","author":"Cw","year":"2023","journal-title":"J\u00a0Am Soc Cytopathol"},{"issue":"7","key":"10.1016\/j.path.2024.04.008_bib63","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/cncy.22398","article-title":"Diagnostic mesothelioma biomarkers in effusion\u00a0cytology","volume":"129","author":"Eccher","year":"2021","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"10.1016\/j.path.2024.04.008_bib64","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cncy.22509","article-title":"Evidence-based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology","volume":"130","author":"Girolami","year":"2022","journal-title":"Cancer Cytopathol"},{"issue":"12","key":"10.1016\/j.path.2024.04.008_bib65","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/cncy.22326","article-title":"Testing for BAP1 loss and CDKN2A\/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology","volume":"128","author":"Chevrier","year":"2020","journal-title":"Cancer Cytopathol"},{"issue":"5","key":"10.1016\/j.path.2024.04.008_bib66","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/cncy.22548","article-title":"Analysis of early pleural fluid samples in patients with mesothelioma: A case series exploration of morphology, BAP1, and CDKN2A status with implications for the concept of mesothelioma in situ in cytology","volume":"130","author":"Louw","year":"2022","journal-title":"Cancer Cytopathol"},{"issue":"10","key":"10.1016\/j.path.2024.04.008_bib67","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.amjmed.2022.04.017","article-title":"Malignant pleural effusion: presentation, diagnosis, and management","volume":"135","author":"Gayen","year":"2022","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.path.2024.04.008_bib68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MCP.0000000000000659","article-title":"Approach to stage IV non-small-cell lung cancer: how to select among first-line therapy options?","volume":"26","author":"Pacheco","year":"2020","journal-title":"Curr Opin Pulm Med"},{"issue":"2","key":"10.1016\/j.path.2024.04.008_bib69","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jso.27165","article-title":"The \u201cnew\u201d oligometastatic disease state and associated therapies in non-small cell lung cancer: A narrative review","volume":"127","author":"Na","year":"2023","journal-title":"J\u00a0Surg Oncol"},{"issue":"18","key":"10.1016\/j.path.2024.04.008_bib70","doi-asserted-by":"crossref","first-page":"e15450","DOI":"10.1097\/MD.0000000000015450","article-title":"Pleural effusion as a substitute for tumor tissue in detecting EGFR\/ALK mutations in non-small cell lung cancer: A systematic review and meta-analysis","volume":"98","author":"Pang","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.path.2024.04.008_bib71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lungcan.2022.10.013","article-title":"EGFR testing in paraffin-embedded cell block cytology material is reliable with increased detection for effusion fluid","volume":"174","author":"Man Ng","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.path.2024.04.008_bib72","doi-asserted-by":"crossref","first-page":"7","DOI":"10.25259\/Cytojournal_18_2021","article-title":"Adequacy of pleural fluid cytology for comprehensive molecular analysis of lung adenocarcinoma: Experience of a large health-care system","volume":"19","author":"Dalvi","year":"2022","journal-title":"CytoJournal"},{"key":"10.1016\/j.path.2024.04.008_bib73","first-page":"969084","article-title":"Breast carcinoma cells in primary tumors and effusions have different gene array profiles","volume":"2010","author":"Konstantinovsky","year":"2010","journal-title":"JAMA Oncol"},{"issue":"9","key":"10.1016\/j.path.2024.04.008_bib74","doi-asserted-by":"crossref","first-page":"e1356","DOI":"10.1002\/ctm2.1356","article-title":"Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions","volume":"13","author":"Whitfield","year":"2023","journal-title":"Clin Transl Med"},{"issue":"9","key":"10.1016\/j.path.2024.04.008_bib75","article-title":"Combined detection of Her2\/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer","volume":"136","author":"B","year":"2010","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib76","article-title":"Discordant HER2 status between primary breast carcinoma and recurrent\/metastatic tumors using fluorescence in situ hybridization on cytological samples","volume":"43","author":"K","year":"2013","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.path.2024.04.008_bib77","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","article-title":"The genomic landscape of endocrine-resistant advanced breast cancers","volume":"34","author":"Razavi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.path.2024.04.008_bib78","doi-asserted-by":"crossref","first-page":"1138759","DOI":"10.3389\/fonc.2023.1138759","article-title":"Malignant ascites in pancreatic cancer: Pathophysiology, diagnosis, molecular characterization, and therapeutic strategies","volume":"13","author":"Han","year":"2023","journal-title":"Front Oncol"},{"issue":"27","key":"10.1016\/j.path.2024.04.008_bib79","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","article-title":"Colorectal peritoneal metastases: Optimal management review","volume":"25","author":"S\u00e1nchez-Hidalgo","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.path.2024.04.008_bib80","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/dc.24165","article-title":"Seriate cytology vs molecular analysis of peritoneal washing to improve gastric cancer cells detection","volume":"47","author":"Taffon","year":"2019","journal-title":"Diagn Cytopathol"},{"issue":"8","key":"10.1016\/j.path.2024.04.008_bib81","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/cncy.22596","article-title":"Molecular analysis of ascitic fluid cytology reflects genetic changes of malignancies of the ovary equivalent to surgically resected specimens","volume":"130","author":"Nozaki","year":"2022","journal-title":"Cancer Cytopathol"},{"issue":"30","key":"10.1016\/j.path.2024.04.008_bib82","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1200\/JCO.20.01924","article-title":"PARP inhibitors in the management of ovarian cancer: ASCO Guideline","volume":"38","author":"Tew","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib83","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12885-019-5535-2","article-title":"Cytology material is equivalent to tumor tissue in determining mutations of BRCA 1\/2 genes in patients with tubo-ovarian high grade serous carcinoma","volume":"19","author":"Gornjec","year":"2019","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.path.2024.04.008_bib84","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/cncy.22484","article-title":"Validation of BRCA testing on cytologic samples of high-grade serous carcinoma","volume":"129","author":"Lou","year":"2021","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.path.2024.04.008_bib85","doi-asserted-by":"crossref","first-page":"712754","DOI":"10.3389\/fonc.2021.712754","article-title":"Targeted sequencing of ascites and peritoneal washing fluid of patients with gastrointestinal cancers and their clinical applications and limitations","volume":"11","author":"Bae","year":"2021","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.path.2024.04.008_bib86","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/jclinpath-2013-201728","article-title":"The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies","volume":"66","author":"Liu","year":"2013","journal-title":"J\u00a0Clin Pathol"},{"issue":"2","key":"10.1016\/j.path.2024.04.008_bib87","doi-asserted-by":"crossref","first-page":"e89946","DOI":"10.1371\/journal.pone.0089946","article-title":"Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.path.2024.04.008_bib88","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/1535-7163.MCT-16-0436","article-title":"Cell-Free DNA from ascites and pleural effusions: molecular insights into genomic aberrations and disease biology","volume":"16","author":"Husain","year":"2017","journal-title":"Mol Cancer Therapeut"},{"issue":"6","key":"10.1016\/j.path.2024.04.008_bib89","first-page":"2110","article-title":"Rapid point-of-care testing for epidermal growth factor receptor gene mutations in patients with lung cancer using cell-free DNA from cytology specimen supernatants","volume":"52","author":"Asaka","year":"2018","journal-title":"Int J Oncol"},{"issue":"5","key":"10.1016\/j.path.2024.04.008_bib90","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3343\/alm.2019.39.5.478","article-title":"Comparison of cobas EGFR Mutation Test v2 and PANAMutyper-R-EGFR for Detection and Semi-Quantification of Epidermal Growth Factor Receptor Mutations in Plasma and Pleural Effusion Supernatant","volume":"39","author":"Han","year":"2019","journal-title":"Ann Lab Med"},{"issue":"19","key":"10.1016\/j.path.2024.04.008_bib91","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.7150\/thno.34070","article-title":"Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer","volume":"9","author":"Tong","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib92","doi-asserted-by":"crossref","first-page":"00016","DOI":"10.1183\/23120541.00016-2019","article-title":"Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions","volume":"5","author":"Hummelink","year":"2019","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.path.2024.04.008_bib93","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jmoldx.2020.01.011","article-title":"Molecular profiling for supernatants and matched cell pellets of pleural effusions in non-small-cell lung cancer","volume":"22","author":"Xiang","year":"2020","journal-title":"J\u00a0Mol Diagn"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib94","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/cncy.22205","article-title":"Targeted deep sequencing of cell-free DNA in serous body cavity fluids with malignant, suspicious, and benign cytology","volume":"128","author":"Yang","year":"2020","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib95","first-page":"277","article-title":"Yang","volume":"147","author":"Mayo-de-Las-Casas","year":"2020","journal-title":"Int J Cancer"},{"issue":"13","key":"10.1016\/j.path.2024.04.008_bib96","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1245\/s10434-020-08832-9","article-title":"Peritoneal cell-free tumor DNA as biomarker for peritoneal surface malignancies","volume":"27","author":"Leick","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.path.2024.04.008_bib97","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/cam4.3769","article-title":"Multigene PCR using both cfDNA and cfRNA in the supernatant of pleural effusion achieves accurate and rapid detection of mutations and fusions of driver genes in patients with advanced NSCLC","volume":"10","author":"Chen","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.path.2024.04.008_bib98","doi-asserted-by":"crossref","first-page":"613071","DOI":"10.3389\/pore.2021.613071","article-title":"Cell-free DNA From Pleural Effusion Samples: Is It Right for Molecular Testing in Lung Adenocarcinoma?","volume":"27","author":"Mok\u00e1nszki","year":"2021","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.path.2024.04.008_bib99","doi-asserted-by":"crossref","first-page":"100449","DOI":"10.1016\/j.ctarc.2021.100449","article-title":"Sensitive cell-free tumor DNA analysis in supernatant pleural effusions supports therapy selection and disease monitoring of lung cancer patients","volume":"29","author":"de Kock","year":"2021","journal-title":"Cancer Treat Res Commun"},{"issue":"4","key":"10.1016\/j.path.2024.04.008_bib100","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1245\/s10434-020-08990-w","article-title":"Peritoneal lavage tumor DNA as a novel biomarker for predicting peritoneal recurrence in pancreatic ductal adenocarcinoma","volume":"28","author":"Suenaga","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.path.2024.04.008_bib101","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cjp2.207","article-title":"Detection of tumor-derived cell-free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid","volume":"7","author":"Van\u2019t Erve","year":"2021","journal-title":"J\u00a0Pathol Clin Res"},{"issue":"10","key":"10.1016\/j.path.2024.04.008_bib102","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3390\/cancers14102506","article-title":"Whole-exome sequencing reveals clinical potential of circulating tumor DNA from peritoneal fluid and plasma in endometrial cancer","volume":"14","author":"Ju","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.path.2024.04.008_bib103","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1186\/s12885-022-09922-5","article-title":"Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers","volume":"22","author":"Wu","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.path.2024.04.008_bib104","doi-asserted-by":"crossref","first-page":"e2200246","DOI":"10.1200\/PO.22.00246","article-title":"Impact of clinical practice gaps on the implementation of personalized medicine in advanced non-small-cell lung cancer","volume":"6","author":"Sadik","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"2","key":"10.1016\/j.path.2024.04.008_bib105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/cyt.12517","article-title":"A\u00a0Combined test using both cell sediment and supernatant cell-free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung cancer patients","volume":"29","author":"Kawahara","year":"2018","journal-title":"Cytopathology"},{"key":"10.1016\/j.path.2024.04.008_bib106","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2019.08.004","article-title":"Cytological-negative pleural effusion can be an alternative liquid\u00a0biopsy media for detection of EGFR mutation in NSCLC patients","volume":"136","author":"Song","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.path.2024.04.008_bib107","doi-asserted-by":"crossref","first-page":"810124","DOI":"10.3389\/fonc.2022.810124","article-title":"Cytology-Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non-Small Cell Lung Cancer","volume":"12","author":"Chiang","year":"2022","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.path.2024.04.008_bib108","doi-asserted-by":"crossref","first-page":"100195","DOI":"10.1016\/j.modpat.2023.100195","article-title":"Artificial intelligence-driven morphology-based enrichment of malignant cells from body fluid","volume":"36","author":"Mavropoulos","year":"2023","journal-title":"Mod Pathol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918124000199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918124000199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T14:32:30Z","timestamp":1723300350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918124000199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1875918124000199"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2024.04.008","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimally Invasive, Maximally Effective","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2024.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}